Browsing by Author Matthews, David. R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2018Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Neal, Bruce; Perkovic, Vlado; Barrett, Terrance D; de Zeeuw, Dick; Desai, Mehul; Figtree, Gemma; Fulcher, Greg; Mahaffey, Kenneth W; Matthews, David. R.; Radholm, Karin; Shaw, Wayne; Solomon, Scott; The George Institute for Global HealthCanagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study), Circulation, vol.138, 5, 2018,pp 458-468
2015Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Mahaffey, Kenneth W; Matthews, David. R.; Meininger, G; Rosenstock, Julio; Shaw, Wayne; Vercruysse, Frank; Weiss, Robert; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial, Diabetes Therapy, vol.6, 3, 2015,pp 289-302
2016Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetesFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Mahaffey, Kenneth W; Mathieu, Chantal; Matthews, David. R.; Meininger, G; Shaw, Wayne; Vercruysse, Frank; Woo, Vincent; Wysham, C; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes, Diabetes, Obesity and Metabolism, vol.18, 1, 2016,pp 82-91
2014Follow-up of blood-pressure lowering and glucose control in type 2 diabetesArima, Hisatomi; Billot, Laurent; Chalmers, John; Colagiuri, Stephen; Hirakawa, Yoichiro; Joshi, Rohina; Li, Qiang; MacMahon, Stephen William; Monaghan, Helen; Neal, Bruce; Patel, Anushka; Perkovic, Vlado; Rodgers, Anthony; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; et al, Various; Glasziou, Paul P; Grobbee, Diederick E.; Hamet, Pavel; Harrap, Stephen; Heller, Simon; Lisheng, Liu; Mancia, Giuseppe; Marre, Michel; Matthews, David. R.; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthFollow-up of blood-pressure lowering and glucose control in type 2 diabetes, The New England Journal of Medicine, vol.371, 15, 2014,pp 1392-1406
2016Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk scoreChalmers, John; Hirakawa, Yoichiro; Jardine, Meg; Kengne, Andre; Patel, Anushka; Woodward, Mark; Zoungas, Sophia; Cooper, Mark; Grobbee, R; Matthews, David. R.; Poulter, Neil; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthPrediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score, Diabetes, Obesity and Metabolism, vol.18, 3, 2016,pp 289-294